Hohlfeld T, Hearse D J, Yellon D M, Isselhard W
Institute of Experimental Medicine, University of Cologne, FRA.
Basic Res Cardiol. 1989 Sep-Oct;84(5):499-509. doi: 10.1007/BF01908202.
The adenosine triphosphate (ATP) content of isolated Langendorff-perfused rat hearts may be increased by more than 40% above the normal value by a 2-h perfusion with adenosine (15 mumol/l). This metabolic manipulation was used to investigate the hypothetical relationship between total tissue ATP content and ischaemia-induced contractile failure, ischaemic contracture and post-ischaemic functional recovery. Adenosine perfused hearts were submitted to 20 min of normothermic ischaemia and reperfused for 45 min with or without adenosine. Control experiments were performed with adenosine-free preischaemic perfusion. In identically designed experiments the tissue-protective effect of diltiazem (0.5 mumol/l) was determined and compared with the experiments with adenosine. At the end of 120 min of preischaemic perfusion, the ATP content of the adenosine treated hearts was 34.3 +/- 1.8 mumol/g dry weight (control = 23.6 +/- 1.9 mumol/g, p less than 0.01). After a period of 20 min of normothermic ischaemia, the ATP content of the adenosine hearts decreased to 13.3 +/- .4 mumol/g, whereas ATP fell to 8.3 +/- 1.6 mumol/g in the control hearts. The creatine phosphate (CP) levels of adenosine hearts were significantly lower than those of the control group before ischaemia, but did not show major differences following ischaemia. During ischaemia, the contractile activity measured via an intraventricular balloon catheter, as well as ischaemic contracture did not differ between the adenosine and control hearts. The inclusion of diltiazem into the perfusate significantly delayed the onset of contracture. After 45 min of reperfusion, ATP contents of adenosine and control hearts reached similar values (8.4 +/- 2.3 and 8.3 +/- 2.9 mumol/g, respectively). Inclusion of adenosine (15 mumol/l in the reperfusion perfusate of the adenosine experiments prevented a further decrease, but did not increase tissue ATP content. CP values of all groups showed a partial recovery upon reperfusion, they did not differ significantly. Contractile recovery was equal in all experimental groups except for the diltiazem treated hearts, which showed during the first 10 min of reperfusion an improved mechanical performance. It is concluded that total tissue ATP is not necessarily a good indicator of functional capabilities under conditions of normothermic ischaemia and reperfusion in the isolated rat heart.
用腺苷(15微摩尔/升)对离体Langendorff灌注大鼠心脏进行2小时灌注,可使三磷酸腺苷(ATP)含量比正常值增加40%以上。这种代谢操作被用于研究组织总ATP含量与缺血诱导的收缩功能衰竭、缺血性挛缩以及缺血后功能恢复之间的假设关系。用腺苷灌注的心脏经历20分钟的常温缺血,再灌注45分钟,再灌注时有的含腺苷,有的不含腺苷。对照实验采用缺血前无腺苷灌注。在设计相同的实验中,测定了地尔硫䓬(0.5微摩尔/升)的组织保护作用,并与腺苷实验进行比较。在缺血前灌注120分钟结束时,腺苷处理组心脏的ATP含量为34.3±1.8微摩尔/克干重(对照组为23.6±1.9微摩尔/克,p<0.01)。经过20分钟的常温缺血后,腺苷处理组心脏的ATP含量降至13.3±0.4微摩尔/克,而对照组心脏的ATP降至8.3±1.6微摩尔/克。腺苷处理组心脏缺血前的磷酸肌酸(CP)水平显著低于对照组,但缺血后未显示出主要差异。缺血期间,通过心室内球囊导管测量的收缩活动以及缺血性挛缩在腺苷处理组和对照组心脏之间没有差异。在灌注液中加入地尔硫䓬可显著延迟挛缩的发生。再灌注45分钟后,腺苷处理组和对照组心脏的ATP含量达到相似值(分别为8.4±2.3和8.3±2.9微摩尔/克)。在腺苷实验的再灌注灌注液中加入腺苷(15微摩尔/升)可防止进一步降低,但未增加组织ATP含量。所有组的CP值在再灌注时均有部分恢复,差异不显著。除地尔硫䓬处理组心脏外,所有实验组的收缩功能恢复情况相同,地尔硫䓬处理组心脏在再灌注的前10分钟显示出机械性能改善。结论是,在离体大鼠心脏常温缺血和再灌注条件下,组织总ATP不一定是功能能力的良好指标。